NPPB and pulmonary arterial hypertension: For example, a greater proportion of patients on anticoagulation received PAH parenteral and combination therapy, and had higher brain natriuretic peptide and NYHA/WHO functional class, which may well reflect that sicker PAH patients were more likely to be anticoagulated at baseline.